{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:58:34Z","timestamp":1792184314198,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Snakebite envenoming is a serious condition requiring medical attention and administration of antivenom. Current antivenoms are antibody preparations obtained from the plasma of animals immunised with whole venom(s) and contain antibodies against snake venom toxins, but also against other antigens. In order to better understand the molecular interactions between antivenom antibodies and epitopes on snake venom toxins, a high-throughput immuno-profiling study on all manually curated toxins from <jats:italic>Dendroaspis<\/jats:italic> species and selected African <jats:italic>Naja<\/jats:italic> species was performed based on custom-made high-density peptide microarrays displaying linear toxin fragments. By detection of binding for three different antivenoms and performing an alanine scan, linear elements of epitopes and the positions important for binding were identified. A strong tendency of antivenom antibodies recognizing and binding to epitopes at the functional sites of toxins was observed. With these results, high-density peptide microarray technology is for the first time introduced in the field of toxinology and molecular details of the evolution of antibody-toxin interactions based on molecular recognition of distinctive toxic motifs are elucidated.<\/jats:p>","DOI":"10.1038\/srep36629","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T13:06:11Z","timestamp":1478610371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["High-throughput immuno-profiling of mamba (Dendroaspis) venom toxin epitopes using high-density peptide microarrays"],"prefix":"10.1038","volume":"6","author":[{"given":"Mikael","family":"Engmark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Laustsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"de Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens V.","family":"Kringelum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,8]]},"reference":[{"key":"BFsrep36629_CR1","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.jprot.2011.05.027","volume":"74","author":"DJ Williams","year":"2011","unstructured":"Williams, D. J. et al. Ending the drought: New strategies for improving the flow of affordable, effective antivenoms in Asia and Africa. Journal of Proteomics 74, 1735\u20131767 (2011).","journal-title":"Journal of Proteomics"},{"key":"BFsrep36629_CR2","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.toxicon.2009.11.020","volume":"56","author":"JM Guti\u00e9rrez","year":"2010","unstructured":"Guti\u00e9rrez, J. M., Williams, D., Fan, H. W. & Warrell, D. A. Snakebite envenoming from a global perspective: Towards an integrated approach. Toxicon 56, 1223\u20131235 (2010).","journal-title":"Toxicon"},{"issue":"34","key":"BFsrep36629_CR3","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.2174\/1381612822666160623073438","volume":"22","author":"Andreas Laustsen","year":"2016","unstructured":"Laustsen, A. H. et al. From Fangs to Pharmacology: The Future of Snakebite Envenoming Therapy. Current Pharmaceutical Design 22 (2016).","journal-title":"Current Pharmaceutical Design"},{"key":"BFsrep36629_CR4","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.jprot.2011.06.019","volume":"74","author":"RA Harrison","year":"2011","unstructured":"Harrison, R. A. et al. Research strategies to improve snakebite treatment: Challenges and progress. Journal of Proteomics 74, 1768\u20131780 (2011).","journal-title":"Journal of Proteomics"},{"key":"BFsrep36629_CR5","doi-asserted-by":"crossref","unstructured":"Le\u00f3n, G. et al. Industrial Production and Quality Control of Snake Antivenoms. In Gopalakrishnakone, P. & Calvete, J. J. (eds) Toxinology, 1\u201322 (Springer Netherlands, Dordrecht, 2014).","DOI":"10.1007\/978-94-007-6649-5_24-3"},{"key":"BFsrep36629_CR6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.toxicon.2013.06.004","volume":"72","author":"SG De-Simone","year":"2013","unstructured":"De-Simone, S. G. et al. Linear B-cell epitopes in BthTX-1, BthTX-II and BthA-1, phospholipase A2\u2019s from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom. Toxicon 72, 90\u2013101 (2013).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR7","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.toxicon.2012.05.028","volume":"60","author":"B Lomonte","year":"2012","unstructured":"Lomonte, B. Identification of linear B-cell epitopes on myotoxin II, a Lys49 phospholipase A2 homologue from Bothrops asper snake venom. Toxicon 60, 782\u2013790 (2012).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR8","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.toxicon.2009.12.015","volume":"56","author":"JJ Calvete","year":"2010","unstructured":"Calvete, J. J. Antivenomics and venom phenotyping: A marriage of convenience to address the performance and range of clinical use of antivenoms. Toxicon 56, 1284\u20131291 (2010).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jprot.2014.02.021","volume":"105","author":"JM Guti\u00e9rrez","year":"2014","unstructured":"Guti\u00e9rrez, J. M., Lomonte, B., Sanz, L., Calvete, J. J. & Pla, D. Immunological profile of antivenoms: Preclinical analysis of the efficacy of a polyspecific antivenom through antivenomics and neutralization assays. Journal of Proteomics 105, 340\u2013350 (2014).","journal-title":"Journal of Proteomics"},{"key":"BFsrep36629_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxicon.2013.03.020","volume":"75","author":"JJ Calvete","year":"2013","unstructured":"Calvete, J. J. Snake venomics: From the inventory of toxins to biology. Toxicon 75, 44\u201362 (2013).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0163-7258(85)90049-X","volume":"30","author":"A M\u00e9nez","year":"1985","unstructured":"M\u00e9nez, A. Molecular immunology of snake toxins. Pharmacology & Therapeutics 30, 91\u2013113 (1985).","journal-title":"Pharmacology & Therapeutics"},{"key":"BFsrep36629_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.toxicon.2014.10.015","volume":"93","author":"KL Castro","year":"2015","unstructured":"Castro, K. L. et al. Identification and characterization of B-cell epitopes of 3FTx and PLA2 toxins from Micrurus corallinus snake venom. Toxicon 93, 51\u201360 (2015).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR13","doi-asserted-by":"crossref","first-page":"e0004484","DOI":"10.1371\/journal.pntd.0004484","volume":"10","author":"HR Ramos","year":"2016","unstructured":"Ramos, H. R. et al. A Heterologous multiepitope DNA prime\/recombinant protein boost immunisation strategy for the development of an antiserum against Micrurus corallinus (coral snake) venom. PLOS Negl Trop Dis 10, e0004484 (2016).","journal-title":"PLOS Negl Trop Dis"},{"key":"BFsrep36629_CR14","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2016.02.035","volume":"34","author":"FS Schneider","year":"2016","unstructured":"Schneider, F. S. et al. Identification of protective B-cell epitopes of Atroxlysin-I: A metalloproteinase from Bothrops atrox snake venom. Vaccine 34, 1680\u20131687 (2016).","journal-title":"Vaccine"},{"key":"BFsrep36629_CR15","doi-asserted-by":"crossref","first-page":"e2693","DOI":"10.1371\/journal.pntd.0002693","volume":"8","author":"CCR Horta","year":"2014","unstructured":"Horta, C. C. R. et al. Molecular, immunological, and biological characterization of Tityus serrulatus venom hyaluronidase: new insights into its role in envenomation. PLoS Neglected Tropical Diseases 8, e2693 (2014).","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"BFsrep36629_CR16","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.toxicon.2005.03.024","volume":"46","author":"W Maria","year":"2005","unstructured":"Maria, W. et al. Localization of epitopes in the toxins of Tityus serrulatus scorpions and neutralizing potential of therapeutic antivenoms. Toxicon 46, 210\u2013217 (2005).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.toxicon.2015.03.018","volume":"99","author":"T Mendes","year":"2015","unstructured":"Mendes, T. et al. General characterization of Tityus fasciolatus scorpion venom. Molecular identification of toxins and localization of linear B-cell epitopes. Toxicon 99, 109\u2013117 (2015).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxicon.2013.07.007","volume":"73","author":"JS Ramada","year":"2013","unstructured":"Ramada, J. S. et al. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms. Toxicon 73, 47\u201355 (2013).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1580\/1080-6032(1996)007[0133:BATOTM]2.3.CO;2","volume":"7","author":"PS Hodgson","year":"1996","unstructured":"Hodgson, P. S. & Davidson, T. M. Biology and treatment of the mamba snakebite. Wilderness & Environmental Medicine 7, 133\u2013145 (1996).","journal-title":"Wilderness & Environmental Medicine"},{"key":"BFsrep36629_CR20","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0742-8413(91)90272-U","volume":"99","author":"N-H Tan","year":"1991","unstructured":"Tan, N.-H., Arunmozhiarasi, A. & Ponnudurai, G. A comparative study of the biological properties of Dendroaspis (mamba) snake venoms. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 99, 463\u2013466 (1991).","journal-title":"Comparative Biochemistry and Physiology Part C: Comparative Pharmacology"},{"key":"BFsrep36629_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jprot.2016.02.003","volume":"136","author":"LP Lauridsen","year":"2016","unstructured":"Lauridsen, L. P., Laustsen, A. H., Lomonte, B. & Guti\u00e9rrez, J. M. Toxicovenomics and antivenom profiling of the Eastern green mamba snake (Dendroaspis angusticeps). Journal of Proteomics 136, 248\u2013261 (2016).","journal-title":"Journal of Proteomics"},{"key":"BFsrep36629_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jprot.2015.02.002","volume":"119","author":"AH Laustsen","year":"2015","unstructured":"Laustsen, A. H., Lomonte, B., Lohse, B., Fern\u00e1ndez, J. & Guti\u00e9rrez, J. M. Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development. Journal of Proteomics 119, 126\u2013142 (2015).","journal-title":"Journal of Proteomics"},{"key":"BFsrep36629_CR23","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jprot.2016.06.018","volume":"146","author":"D Petras","year":"2016","unstructured":"Petras, D., Heiss, P., Harrison, R. A., S\u00fcssmuth, R. D. & Calvete, J. J. Top-down venomics of the East African green mamba, Dendroaspis angusticeps, and the black mamba, Dendroaspis polylepis, highlight the complexity of their toxin arsenals. Journal of Proteomics 146, 148\u2013164 (2016).","journal-title":"Journal of Proteomics"},{"key":"BFsrep36629_CR24","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.toxicon.2010.07.010","volume":"56","author":"RM Kini","year":"2010","unstructured":"Kini, R. M. & Doley, R. Structure, function and evolution of three-finger toxins: Mini proteins with multiple targets. Toxicon 56, 855\u2013867 (2010).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0041-0101(00)00162-8","volume":"39","author":"AL Harvey","year":"2001","unstructured":"Harvey, A. L. Twenty years of dendrotoxins. Toxicon 39, 15\u201326 (2001).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3940(87)90612-4","volume":"77","author":"F Dajas","year":"1987","unstructured":"Dajas, F., Bolioli, B., Castello, M. E. & Silveira, R. Rat striatal acetylcholinesterase inhibition by Fasciculin (a polypeptide from green mamba snake venom). Neuroscience Letters 77, 87\u201391 (1987).","journal-title":"Neuroscience Letters"},{"key":"BFsrep36629_CR27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00239-003-2461-2","volume":"57","author":"BG Fry","year":"2003","unstructured":"Fry, B. G. et al. Molecular evolution and phylogeny of elapid snake venom three-finger toxins. Journal of Molecular Evolution 57, 110\u2013129 (2003).","journal-title":"Journal of Molecular Evolution"},{"key":"BFsrep36629_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-4939-3167-5_2","volume":"1374","author":"E Boutet","year":"2016","unstructured":"Boutet, E. et al. UniProtKB\/Swiss-Prot, the Manually Annotated Section of the UniProt KnowledgeBase: How to Use the Entry View. Methods in Molecular Biology (Clifton, N.J.) 1374, 23\u201354 (2016).","journal-title":"Methods in Molecular Biology (Clifton, N.J.)"},{"key":"BFsrep36629_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/B:MODI.0000036233.58271.25","volume":"8","author":"X Gao","year":"2004","unstructured":"Gao, X. et al. High density peptide microarrays. In situ synthesis and applications. Molecular Diversity 8, 177\u2013187 (2004).","journal-title":"Molecular Diversity"},{"key":"BFsrep36629_CR30","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1074\/mcp.M112.020800","volume":"11","author":"S Buus","year":"2012","unstructured":"Buus, S. et al. High-resolution mapping of linear antibody epitopes using ultrahigh-density peptide microarrays. Molecular & Cellular Proteomics 11, 1790\u20131800 (2012).","journal-title":"Molecular & Cellular Proteomics"},{"key":"BFsrep36629_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.molimm.2012.06.001","volume":"53","author":"JV Kringelum","year":"2013","unstructured":"Kringelum, J. V., Nielsen, M., Padkj\u00e6r, S. B. & Lund, O. Structural analysis of B-cell epitopes in antibody:protein complexes. Molecular Immunology 53, 24\u201334 (2013).","journal-title":"Molecular Immunology"},{"key":"BFsrep36629_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.94.1","volume":"94","author":"S Nirthanan","year":"2004","unstructured":"Nirthanan, S. & Gwee, M. C. Three-finger \u03b1-neurotoxins and the nicotinic acetylcholine receptor, forty years on. Journal of pharmacological sciences 94, 1\u201317 (2004).","journal-title":"Journal of pharmacological sciences"},{"key":"BFsrep36629_CR33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1107\/S0907444900010659","volume":"56","author":"G Kryger","year":"2000","unstructured":"Kryger, G. et al. Structures of recombinant native and E202q mutant human acetylcholinesterase complexed with the snake-venom toxin fasciculin-II. Acta Crystallographica Section D-Biological Crystallography 56, 1385\u20131394, WOS: 000165336100004 (2000).","journal-title":"Acta Crystallographica Section D-Biological Crystallography"},{"key":"BFsrep36629_CR34","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1021\/bi9802723","volume":"37","author":"RM Kini","year":"1998","unstructured":"Kini, R. M. et al. Flanking proline residues identify the L-type Ca2+ channel binding site of calciseptine and FS2. Biochemistry 37, 9058\u20139063 (1998).","journal-title":"Biochemistry"},{"key":"BFsrep36629_CR35","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1021\/bi00017a022","volume":"34","author":"J Albrand","year":"1995","unstructured":"Albrand, J., Blackledge, M., Pascaud, F., Hollecker, M. & Marion, D. NMR and restrained molecular-dynamics study of the 3-dimensional solution structure of toxin FS2, a specific blocker of the L-type calcium-channel, isolated from black mamba venom. Biochemistry 34, 5923\u20135937, WOS:A1995QW14600022 (1995).","journal-title":"Biochemistry"},{"key":"BFsrep36629_CR36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1042\/BJ20130636","volume":"454","author":"S Huang","year":"2013","unstructured":"Huang, S. et al. Complex between \u03b1-bungarotoxin and an \u03b17 nicotinic receptor ligand-binding domain chimaera. Biochemical Journal 454, 303\u2013310 (2013).","journal-title":"Biochemical Journal"},{"key":"BFsrep36629_CR37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0896-6273(02)00773-0","volume":"35","author":"AO Samson","year":"2002","unstructured":"Samson, A. O., Scherf, T., Eisenstein, M., Chill, J. H. & Anglister, J. The mechanism for acetylcholine receptor inhibition by \u03b1-neurotoxins and species-specific resistance to \u03b1-bungarotoxin revealed by NMR. Neuron 35, 319\u2013332 (2002).","journal-title":"Neuron"},{"key":"BFsrep36629_CR38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-4682-6-3","volume":"6","author":"A Nasiripourdori","year":"2009","unstructured":"Nasiripourdori, A., Ranjbar, B. & Naderi-Manesh, H. Binding of long-chain \u03b1-neurotoxin would stabilize the resting state of nAChR: A comparative study with \u03b1-conotoxin. Theoretical Biology and Medical Modelling 6, 3 (2009).","journal-title":"Theoretical Biology and Medical Modelling"},{"key":"BFsrep36629_CR39","doi-asserted-by":"crossref","first-page":"e0151363","DOI":"10.1371\/journal.pone.0151363","volume":"11","author":"NDR Prado","year":"2016","unstructured":"Prado, N. D. R. et al. Inhibition of the myotoxicity induced by Bothrops jararacussu venom and isolated phospholipases A2 by specific camelid single-domain antibody fragments. PLOS ONE 11, e0151363 (2016).","journal-title":"PLOS ONE"},{"key":"BFsrep36629_CR40","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nature04328","volume":"439","author":"BG Fry","year":"2006","unstructured":"Fry, B. G. et al. Early evolution of the venom system in lizards and snakes. Nature 439, 584\u2013588 (2006).","journal-title":"Nature"},{"key":"BFsrep36629_CR41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.toxicon.2015.07.334","volume":"104","author":"AH Laustsen","year":"2015","unstructured":"Laustsen, A. H., Brian, Lohse, Lomonte, B., Engmark, M. & Guti\u00e9rrez, J. M. Selecting key toxins for focused development of elapid snake antivenoms and inhibitors guided by a Toxicity Score. Toxicon 104, 43\u201345 (2015).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR42","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vaccine.2008.10.066","volume":"27","author":"V Arce-Estrada","year":"2009","unstructured":"Arce-Estrada, V., Azofeifa-Cordero, G., Estrada, R., Alape-Gir\u00f3n, A. & Flores-D\u00edaz, M. Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper. Vaccine 27, 460\u2013466 (2009).","journal-title":"Vaccine"},{"key":"BFsrep36629_CR43","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.toxicon.2008.05.023","volume":"52","author":"G Azofeifa-Cordero","year":"2008","unstructured":"Azofeifa-Cordero, G., Arce-Estrada, V., Flores-D\u00edaz, M. & Alape-Gir\u00f3n, A. Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom. Toxicon 52, 302\u2013308 (2008).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR44","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/j.vaccine.2003.09.046","volume":"22","author":"RA Harrison","year":"2004","unstructured":"Harrison, R. A. Development of venom toxin-specific antibodies by DNA immunisation: rationale and strategies to improve therapy of viper envenoming. Vaccine 22, 1648\u20131655 (2004).","journal-title":"Vaccine"},{"key":"BFsrep36629_CR45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2249.2000.01287.x","volume":"121","author":"RA Harrison","year":"2000","unstructured":"Harrison, R. A. et al. Antibody from mice immunized with DNA encoding the carboxyl-disintegrin and cysteine-rich domain (JD9) of the haemorrhagic metalloprotease, Jararhagin, inhibits the main lethal component of viper venom. Clinical and Experimental Immunology 121, 358\u2013363 (2000).","journal-title":"Clinical and Experimental Immunology"},{"key":"BFsrep36629_CR46","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0264-410X(02)00026-9","volume":"20","author":"RA Harrison","year":"2002","unstructured":"Harrison, R. A., Richards, A., Laing, G. D. & Theakston, R. D. G. Simultaneous GeneGun immunisation with plasmids encoding antigen and GM-CSF: significant enhancement of murine antivenom IgG1 titres. Vaccine 20, 1702\u20131706 (2002).","journal-title":"Vaccine"},{"key":"BFsrep36629_CR47","doi-asserted-by":"crossref","unstructured":"Wagstaff, S. C., Laing, G. D., Theakston, R. D. G., Papaspyridis, C. & Harrison, R. A. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom. PLoS Medicine 3 (2006).","DOI":"10.1371\/journal.pmed.0030184"},{"key":"BFsrep36629_CR48","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3390\/toxins8080226","volume":"8","author":"AH Laustsen","year":"2016","unstructured":"Laustsen, A. H. et al. Biotechnological Trends in Spider and Scorpion Antivenom Development. Toxins 8, 226 (2016).","journal-title":"Toxins"},{"key":"BFsrep36629_CR49","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0041-0101(91)90116-9","volume":"29","author":"JP Chippaux","year":"1991","unstructured":"Chippaux, J. P., Williams, V. & White, J. Snake venom variability: methods of study, results and interpretation. Toxicon 29, 1279\u20131303 (1991).","journal-title":"Toxicon"},{"key":"BFsrep36629_CR50","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2105-12-35","volume":"12","author":"H Chen","year":"2011","unstructured":"Chen, H. & Boutros, P. C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics 12, 35 (2011).","journal-title":"BMC Bioinformatics"},{"key":"BFsrep36629_CR51","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2\u2013Elegant Graphics for Data Analysis (Springer New York, New York, NY, 2009).","DOI":"10.1007\/978-0-387-98141-3"},{"key":"BFsrep36629_CR52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2014","unstructured":"Sievers, F. et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Molecular Systems Biology 7, 539\u2013539 (2014).","journal-title":"Molecular Systems Biology"},{"key":"BFsrep36629_CR53","unstructured":"Id\u2019e, J. Rpdb: Read, write, visualize and manipulate PDB files (2014)."},{"key":"BFsrep36629_CR54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1432-1033.1988.tb14375.x","volume":"177","author":"AM Labhardt","year":"1988","unstructured":"Labhardt, A. M., Hunziker-Kwik, E. H. & W\u00fcthrich, K. Secondary structure determination for \u03b1-neurotoxin from Dendroaspis polylepis polylepis based on sequence-specific 1h-nuclear-magnetic-resonance assignments. European journal of biochemistry\/FEBS 177, 295\u2013305 (1988).","journal-title":"European journal of biochemistry\/FEBS"},{"key":"BFsrep36629_CR55","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","volume":"55","author":"J Cheung","year":"2012","unstructured":"Cheung, J. et al. Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry 55, 10282\u201310286 (2012).","journal-title":"Journal of Medicinal Chemistry"},{"key":"BFsrep36629_CR56","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1021\/bi5004475","volume":"53","author":"C-IA Wang","year":"2014","unstructured":"Wang, C.-I. A. et al. Isolation and structural and pharmacological characterization of \u03b1-Elapitoxin-Dpp2d, an amidated three finger toxin from black mamba venom. Biochemistry 53, 3758\u20133766 (2014).","journal-title":"Biochemistry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep36629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36629","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep36629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:43:44Z","timestamp":1672879424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep36629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,8]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep36629"],"URL":"https:\/\/doi.org\/10.1038\/srep36629","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,8]]},"assertion":[{"value":"1 August 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Eric Sullivan and Jigar Patel are full-time employees of Roche NimbleGen. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36629"}}